tv.qiagenbioinformatics.com

The Spring 2026 release of IPA introduces the Comparison Analysis bubble map to IPA Interpret. This feature lets users compare multiple treatments, diseases, cell types and other experimental conditions in a single, customizable and interactive graphic. With support for up to 50 IPA Core Analyses, this bubble map also shows all scored entities – Upstream Regulators, Canonical Pathways and more – i...

QIAGEN Ingenuity Pathway Analysis (IPA) is a tertiary analysis platform that:   - Predicts the activity of pathways, diseases, genes and more - Validates your results against existing research - Interprets your ‘omics data into clear, action-oriented insights   Ready to turn your ‘omics data into discoveries? See how you can leverage expert-curated, AI-augmented knowledge for actionable...

QIAGEN Ingenuity Pathway Analysis (IPA) is a tertiary analysis platform that:   - Predicts the activity of pathways, diseases, genes and more - Validates your results against existing research - Interprets your ‘omics data into clear, action-oriented insights   Ready to turn your ‘omics data into discoveries? See how you can leverage expert-curated, AI-augmented knowledge for actionable...

Accurate variant interpretation is critical in hereditary cancer genetics, but it’s often complex due to conflicting data and evolving clinical context. In this webinar, Molecular Geneticist Dr. Ana Krivokuca will lead a live, case-based demonstration using Franklin by QIAGEN, showing how the platform's structured workflows, ACMG criteria and integrated data can support confident, transparent inte...

Comorbidity data can reveal unexpected and insightful connections between diseases. Understanding shared risks and underlying mechanisms are critical for informing patient care, yet these analyses often present significant challenges for researchers. Using a case study on the correlation between asthma and inflammatory bowel disease (IBD) in women, this webinar will demonstrate how comorbidity dat...

Biomedical KB-HD analysis in Neo4j enables researchers to explore complex relationships between drugs, targets and diseases using a comprehensive biomedical knowledge graph. Explore how to use this expert-curated data to identify promising disease biomarkers and examine their targets for various applications, using GLP-1, diabetes and Alzheimer’s disease as an example. You will learn: - To qu...

Influenza is a highly contagious disease that affects humans and multiple animal hosts. Since influenza viruses are prone to major genetic changes, continuous research is critical for global public health, enabling scientists to anticipate and mitigate the impact of this rapidly evolving pathogen. Our webinar will show how you can analyze and interpret influenza virus sequencing data using QIAGEN...

Welcome to one of our exclusive, hands-on virtual workshops to explore Franklin + HGMD Professional — a powerful variant interpretation and reporting solution combining AI-driven workflows with expertly curated evidence. During this session, you’ll analyze a real-world case involving a 3-month-old patient with complex neuromuscular phenotypes. Using Franklin + HGMD, you’ll prio...

Welcome to one of our exclusive, hands-on virtual workshops to explore Franklin + HGMD Professional — a powerful variant interpretation and reporting solution combining AI-driven workflows with expertly curated evidence. During this session, you’ll analyze a real-world case involving a 3-month-old patient with complex neuromuscular phenotypes. Using Franklin + HGMD, you’ll prio...

QIAGEN OmicSoft Explorer is your portal to thousands of deeply curated and integrated ‘omics datasets. In this hands-on workshop, we will explore projects with cell-level data and use it to investigate relevant studies, diseases or genes of interest using curated metadata terms. See how you can use OmicSoft Explorer by itself or with Ingenuity Pathway Analysis (IPA) to accelerate biological insigh...

ATAC-seq is a powerful technique for assessing chromatin accessibility and identifying regulatory regions across the genome. From bulk ATAC-seq for population-level findings to single-cell ATAC-seq (scATAC-seq) to resolve chromatin accessibility at the individual cell level, these approaches lend deeper insights into gene regulation and cell state. QIAGEN CLC Genomics Workbench Premium provides re...

This 90-minute training session will show you how QIAGEN Ingenuity Pathway Analysis (IPA) helps visualize molecular intricacies and variations at multiple levels, such as transcriptome, proteome and metabolome. Through a series of brief technical vignettes, we will demonstrate how to: - Generate associations among molecular signatures obtained via integrating multi-omics data - Extract mechanisms...

One click from your target gene to disease drivers, drug candidates and causal evidence. The Neo4j & QIAGEN solution transforms causal biomedical knowledge from QIAGEN Discovery KB+ into an interactive discovery surface. Learn how to query biomarkers, navigate causal networks and find drug repositioning candidates,  provenance and natural language summaries included.

NVIDIA and QIAGEN are collaborating to bring trustworthy, contextual AI to drug discovery. By integrating NVIDIA's accelerated computing and the BioNeMo platform with QIAGEN Digital Insights' manually curated biomedical knowledge graphs, cited in over 70,000 peer-reviewed publications; the collaboration aims to transform how disease mechanisms, therapeutic targets, and biomarkers are identified. U...

Single cell experiment viewer (SCEV) enables researchers to explore single-cell experiments in an interactive visual environment, overlaying curated cell metadata and gene expression patterns to reveal biologically meaningful cell states. By applying IPA’s embedding model of causal relationships, SCEV predicts upstream regulators and downstream functions that are likely active in specific cells or...

Explore how CLC Genomics Server enables the transition from ad hoc bioinformatics analyses to a scalable, centrally managed and production-ready infrastructure. We will show how the platform supports: - Secure and centralized compute environments - Controlled deployment of validated workflows - Multi-user access with governance and audit trails - Integration within existing IT and virtualized envi...

As cosmetic science advances, consumers are demanding products better tailored to their specific concerns. What if you could decode skin biology and translate it into targeted cosmetic innovation? Next-generation sequencing (NGS) is deepening our understanding of skin biology by enabling comprehensive, high-throughput analysis of DNA and RNA to identify key genetic and transcriptomic markers assoc...

Understanding the inner workings of the adaptive immune system is critical to new strategies for combatting cancer and infectious diseases. In this webinar led by Drs. Mazza, Mazzotti and de Souza, we will explore T-cell receptor (TCR) repertoire analysis from start to finish, examining the different steps, approaches and data analysis implications. Join us to gain a deeper understanding of the mo...

“Reliable AI”? Sounds like a contradiction, but with HGMD in Franklin, it’s possible.   By combining HGMD Pro’s comprehensive, expert-curated hereditary variant content and Franklin’s AI workflows and user-friendly interface, accelerated hereditary variant interpretation is now within closer reach. Whether you’re in diagnostics, research or bioinformatics, you will gain practical insights int...

Neutrophils, known for killing microbes, can be both beneficial and harmful during a tuberculosis (TB) infection. While neutrophils kill the bacteria early on, they also contribute to chronic inflammation and lung tissue destruction. However, recent studies show that these roles are associated with different subsets of neutrophils: regulatory ones that display major histocompatibility complex (MHC...

Our exclusive, hands-on virtual workshops will  explore Franklin + HGMD Professional: a powerful variant interpretation and reporting solution combining AI-driven workflows with expertly curated evidence. During this session, you’ll analyze a real-world case involving a 3-month-old patient with complex neuromuscular phenotypes. Using Franklin + HGMD, you’ll prioritize vari...

Are you working on or planning an ‘omics project? Newsflash: You don’t need to have data to get insights. Don’t miss out on pre-data findings with QIAGEN Ingenuity Pathway Analysis (IPA). In this deep dive, we’ll focus on building networks of biomolecules and entities (pathways, diseases, biological functions and more). We’ll explore how you can modify it to perform in silico experiments – with or...

Today’s healthcare system largely reacts to illness rather than preventing it. Researchers at Stanford University School of Medicine are pioneering a new approach: using big data, multi-omics technologies, and continuous remote monitoring to understand health while people are still well and detect disease at its earliest, pre-symptomatic stages. By combining genomics, immunomics, transcriptomics,...

The autoimmune drug market is dominated by blockbuster biologics, including Janssen’s Stelara® (ustekinumab), a dual IL-23 and IL-12 inhibitor approved for plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. These biologics generate billions in annual revenue, but when exclusivity ends, competition from biosimilars quickly becomes a concern. Using the real-world example...

The early stages of drug development are inherently high-risk; molecule screening, target evaluation and lead refinement can take years and cost millions of dollars – often have little to show for the effort. Indication expansion and drug repurposing can open new avenues of possibility, after careful evaluation of the relationships between the drug, its targets and the new disease context. These c...